The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...
AllAfrica on MSN
36,000 Liberians Living With HIV/Aids
The National AIDS Commission (NAC) has raised serious concern over a steady increase in HIV cases across Liberia, revealing that the number of people living with the virus has climbed from 34,000 in ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from the pivotal ...
"I was scared and terrified because I was still very young when I received the news. What else was going to save me if the medicines that are supposed to treat me are failing?" wonders Brandon Jaka, a ...
Merck reports positive results from phase 3 trial of once-daily, oral, two-drug, single-tablet regimen of Doravirine/Islatravir in treatment-naïve adults with HIV-1 infection ...
The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...
Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...
Either we get ahead of this crisis or watch a generation of Americans be swept into the devastating grip of disease.
Short jail stays for minor crimes turn deadly when filth and a lack of care let infections run out of control, a USA TODAY ...
WHO emphasizes integrating surveillance into national STI programs. Zoliflodacin, a novel antimicrobial agent, shows promise in treating gonorrhea, demonstrating non-inferiority to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback